APH
Amphenol Corporation
APH has slightly lower modeled downside risk, despite its lower overall score.
MU
Micron Technology, Inc.
MU has the edge over APH overall, supported by stronger valuation and stronger fundamentals.
APH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Healthy |
APH's revenue, profitability, cash flow and balance sheet are all currently healthy.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
APH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $79.62 | — |
| Cheap | 26x | $60.41 | -24% |
| Fair | 33x | $76.08 | -4.4% |
| Current | 35x | $79.62 | — |
| Expensive | 42x | $96.05 | +21% |
Historical ranges are pointers, not guarantees.
APH's PE is in its fair range at 35x. If earnings grow as analysts expect, today's price would be 23x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over APH in the historical PE scenario, which offers more potential upside but is not a forecast.
APH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for APH, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
APH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.46 | +50% |
| Q3 2026 | $2.30 | +53% |
| Q2 2026 | $1.99 | +58% |
| Q1 2026 | $1.74 | +69% |
| Q4 2025 | $1.67 | +74% |
| Q3 2025 | $1.50 | +72% |
| Q2 2025 | $1.26 | +50% |
| Q1 2025 | $1.03 | +26% |
| Q4 2024 | $0.96 | +23% |
APH's earnings per share have climbed steadily: $2.30 over the past year, up 53% from the year before, and higher year over year every quarter since late 2020.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU's earnings per share have climbed steadily: $74.33 over the past year, about 10 times what it earned the year before, and higher year over year for 10 quarters in a row.
APH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.2B | +65% |
| Q2 2026 | $8.8B | +55% |
| Q1 2026 | $7.6B | +58% |
| Q4 2025 | $6.4B | +49% |
| Q3 2025 | $6.2B | +53% |
| Q2 2025 | $5.7B | +57% |
| Q1 2025 | $4.8B | +48% |
| Q4 2024 | $4.3B | +30% |
APH's revenue has grown year over year for 12 quarters in a row: $10.2B last quarter, up 65% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +2.1 points |
| Q2 2026 | 30% | +4.4 points |
| Q1 2026 | 24% | +2.7 points |
| Q4 2025 | 27% | +4.7 points |
| Q3 2025 | 27% | +7.2 points |
| Q2 2025 | 25% | +5.8 points |
| Q1 2025 | 21% | +0.3 points |
| Q4 2024 | 22% | +1.4 points |
APH's operating margin was 30% last quarter, up 2.1 points from the same quarter a year ago, near the top of its range since 2019.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over APH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over APH on profitability, with a higher operating margin.
APH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +34% |
| Q2 2026 | $1.2B | +7.3% |
| Q1 2026 | $829.9M | +44% |
| Q4 2025 | $1.5B | +127% |
| Q3 2025 | $1.2B | +156% |
| Q2 2025 | $1.1B | +114% |
| Q1 2025 | $576.3M | +14% |
| Q4 2024 | $647.3M | -12% |
APH's free cash flow has been positive every quarter for seven years: $5.1B over the past year, up 44% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU generated $59B in free cash flow over the past year, more than ten times what it generated the year before.
APH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +4.5M shares |
| 1 year | +0.7% | +17.3M shares |
| 3 years | +3.8% | +94.9M shares |
| 5 years | +3.2% | +79.7M shares |
| Available history | +4.9% | +120M shares |
APH has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $244.6M |
| Q2 2026 | $208M |
| Q1 2026 | $178M |
| Q4 2025 | $171.3M |
| Q3 2025 | $152.9M |
| Q2 2025 | $160.1M |
| Q1 2025 | $180.9M |
| Q4 2024 | $168.9M |
APH spent $802M buying back its own shares over the past year, up 21% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
APH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.0x | Very low |
APH's net debt is about 1.3 years of its operating earnings (EBITDA), up from less than a year a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over APH on leverage, with a lower net debt burden relative to earnings.
APH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 36.3 | Neutral |
APH's weekly RSI is 52 (neutral) and its Stochastic is 36 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
APH PE vs Technology Sector
| Metric | APH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 24% above |
| PE % | 59 | 35 | 24 pts above |
APH is trading at 35x earnings, a 24% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over APH on valuation relative to its sector.
APH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.7 | 1.3% below |
| 20 week MA | $80.5 | 1% below |
| 50 week MA | $74.5 | 6.9% above |
| 100 week MA | $60.8 | 31% above |
| 200 week MA | $43.4 | 83% above |
APH has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 83% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
APH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.5 | $16.2 | +20% |
| 2021 | $16.2 | $21.3 | +32% |
| 2022 | $21.3 | $19.0 | -11% |
| 2023 | $19.0 | $24.8 | +31% |
| 2024 | $24.8 | $35.4 | +43% |
| 2025 | $35.4 | $68.7 | +94% |
| 2026 YTD | $68.7 | $79.6 | +16% |
APH has finished higher in five of the last six years. It's up 16% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over APH on returns for 2026, with the stronger performance.